| Osarogiagbon, Raymond U |
Baptist Memorial Hospital - Tipton
United States |
Baptist Memorial Health Care/Mid South NCORP Minority Underserved Consortium |
5UG1CA189873-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Bailey, Lisa (Nmn) |
Bay Area Tumor Institute
United States |
Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites |
5UG1CA189817-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Bailey, Lisa (Nmn) |
Bay Area Tumor Institute
United States |
Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites |
5UG1CA189817-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Bailey, Lisa (Nmn) |
Bay Area Tumor Institute
United States |
Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites |
5UG1CA189817-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Bailey, Lisa (Nmn) |
Bay Area Tumor Institute
United States |
Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites |
5UG1CA189817-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Chan, Daniel Wanyui |
Johns Hopkins University
United States |
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs |
1U2CCA271895-01A1 |
|
Indu Kohaar, Ph.D. |
| Prigerson, Holly Gwen |
Weill Medical Coll Of Cornell Univ
United States |
Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) |
5R35CA197730-09 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Tayob, Nabihah |
Dana-Farber Cancer Inst
United States |
Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma |
5R01CA230503-06 |
|
|
| Allen, Peter J |
Duke University
United States |
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas |
2R01CA182076-06A1 |
|
Matthew Young, Ph.D. |
| Simeone, Diane M |
New York University School Of Medicine
United States |
Biomarker Validation in Pancreatic Cystic Neoplasms |
1U01CA282272-01 |
PAR-21-334 (U01 Clinical Trial Optional) |
|